CN Stock MarketDetailed Quotes

688799 Hunan Warrant Pharmaceutical

Watchlist
  • 42.46
  • +0.18+0.43%
Trading Dec 26 13:58 CST
3.98BMarket Cap18.84P/E (TTM)

Hunan Warrant Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
1.28%1.07B
2.43%738.59M
4.38%372.9M
10.84%1.43B
13.89%1.06B
21.74%721.05M
22.36%357.27M
12.74%1.29B
14.97%926.99M
14.02%592.31M
Operating revenue
1.28%1.07B
2.43%738.59M
4.38%372.9M
10.84%1.43B
13.89%1.06B
21.74%721.05M
22.36%357.27M
12.74%1.29B
14.97%926.99M
14.02%592.31M
Total operating cost
4.19%924.38M
4.94%634.77M
4.65%321.93M
8.88%1.21B
10.52%887.21M
18.93%604.89M
20.34%307.62M
13.08%1.11B
15.15%802.78M
13.26%508.6M
Operating cost
7.89%402.68M
4.41%274.93M
-2.96%133.12M
20.89%504.55M
27.13%373.25M
43.13%263.33M
40.16%137.19M
31.82%417.38M
36.33%293.6M
27.22%183.98M
Operating tax surcharges
52.33%18.09M
74.71%11.75M
10.34%3.33M
14.09%19.28M
18.36%11.88M
6.52%6.72M
23.62%3.01M
20.22%16.9M
6.87%10.03M
-4.14%6.31M
Operating expense
-3.53%369.27M
-0.62%250.92M
12.04%138.26M
-3.51%528.1M
-7.13%382.78M
-4.79%252.48M
-4.80%123.4M
2.50%547.31M
5.84%412.16M
8.88%265.17M
Administration expense
0.39%47.08M
10.02%32.81M
22.44%16.97M
38.22%67.25M
41.73%46.9M
36.63%29.82M
32.92%13.86M
-6.43%48.65M
-15.34%33.09M
0.48%21.83M
Financial expense
-312.57%-13.3M
1.57%-2.12M
-335.72%-1.17M
-62.07%-12.32M
32.79%-3.22M
21.69%-2.15M
78.21%-269.42K
-92.05%-7.6M
-92.33%-4.8M
-1,074.75%-2.74M
-Interest Income (Financial expense)
-358.41%-13.68M
-11.46%-1.99M
-151.04%-1.15M
-71.79%-12.44M
28.19%-2.98M
34.33%-1.78M
-343.44%-456.44K
-74.00%-7.24M
-60.60%-4.16M
-498.15%-2.71M
Research and development
32.94%100.56M
21.54%66.47M
3.29%31.43M
16.37%103.18M
28.86%75.64M
60.63%54.69M
84.33%30.43M
26.57%88.67M
26.49%58.7M
3.82%34.05M
Credit Impairment Loss
104.39%337.55K
-630.78%-2.32M
-680.79%-1.1M
31.34%-1.58M
107.79%165.15K
21.46%-316.81K
131.36%188.57K
-39.74%-2.3M
-123.38%-2.12M
0.79%-403.39K
Asset Impairment Loss
53.32%-2.41M
14.38%-2.58M
-24.40%-1.16M
-67.55%-7.59M
-198.80%-5.17M
-3,732.55%-3.01M
-2,489.52%-932.1K
-67.76%-4.53M
-1,246.94%-1.73M
-117.79%-78.59K
Other net revenue
Invest income
-818.25%-11.4M
-246.72%-4.14M
-266.89%-2.85M
-55.06%3.58M
-82.41%1.59M
-59.73%2.82M
-42.02%1.71M
367.29%7.98M
956.45%9.02M
648.54%7.01M
-Including: Investment income associates
-189.28%-11.39M
-151.58%-4.2M
-136.21%-2.9M
-5.91%-5.04M
-135.96%-3.94M
-105.96%-1.67M
-2.88%-1.23M
-86.18%-4.76M
10.00%-1.67M
56.83%-810.58K
Asset deal income
----
----
--0
--200.27
100.03%200.27
100.16%200.27
100.91%200.27
----
-395.76%-673.9K
-83.33%-121.45K
Other revenue
197.81%32.09M
167.97%26.5M
639.58%21.55M
47.68%19.95M
18.27%10.78M
76.71%9.89M
133.23%2.91M
-35.24%13.51M
-44.48%9.11M
-59.78%5.6M
Operating profit
-7.02%163.53M
-3.39%121.29M
25.96%67.42M
20.97%237.11M
27.62%175.88M
31.17%125.55M
34.00%53.52M
7.76%196M
11.79%137.81M
15.26%95.71M
Add:Non operating Income
-47.16%19.54K
-92.22%1.91K
-86.40%1.71K
-39.81%58.41K
-49.90%36.99K
-65.34%24.59K
580.70%12.59K
-72.20%97.05K
-76.83%73.83K
2,187.97%70.93K
Less:Non operating expense
-98.00%111.51K
-98.32%91.46K
-58.67%7.33K
540.46%7.29M
1,718.65%5.58M
2,578.06%5.46M
-82.30%17.74K
-48.46%1.14M
-90.45%306.77K
-93.65%203.86K
Total profit
-4.05%163.44M
0.91%121.2M
25.96%67.41M
17.91%229.88M
23.81%170.34M
25.67%120.11M
34.31%53.52M
8.29%194.96M
14.29%137.58M
19.72%95.58M
Less:Income tax cost
-6.05%24.11M
29.10%21.74M
67.31%14.78M
70.78%36.84M
32.35%25.66M
20.81%16.84M
53.52%8.83M
11.95%21.57M
13.22%19.39M
30.68%13.94M
Net profit
-3.69%139.34M
-3.69%99.46M
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
14.46%118.19M
18.03%81.64M
Net profit from continuing operation
-3.69%139.34M
-3.69%99.46M
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
--118.19M
18.03%81.64M
Less:Minority Profit
-40.33%-19.07M
-49.11%-13.33M
-62.06%-7.42M
-94.19%-18.28M
-128.51%-13.59M
-309.92%-8.94M
---4.58M
---9.42M
---5.95M
---2.18M
Net profit of parent company owners
0.09%158.41M
0.52%112.79M
21.90%60.05M
15.60%211.32M
27.49%158.27M
33.87%112.21M
44.50%49.26M
13.71%182.8M
20.22%124.14M
21.19%83.82M
Earning per share
Basic earning per share
0.00%1.69
0.00%1.2
20.75%0.64
15.38%2.25
28.03%1.69
34.83%1.2
47.22%0.53
-2.99%1.95
20.00%1.32
-9.18%0.89
Diluted earning per share
0.00%1.69
0.00%1.2
20.75%0.64
15.38%2.25
28.03%1.69
34.83%1.2
47.22%0.53
-2.99%1.95
20.00%1.32
-9.18%0.89
Other composite income
Total composite income
-3.69%139.34M
-3.69%99.46M
17.79%52.63M
11.33%193.04M
22.41%144.68M
26.50%103.27M
31.07%44.68M
7.86%173.39M
118.19M
18.03%81.64M
Total composite income of parent company owners
0.09%158.41M
0.52%112.79M
21.90%60.05M
15.60%211.32M
27.49%158.27M
33.87%112.21M
44.50%49.26M
13.71%182.8M
--124.14M
21.19%83.82M
Total composite income of minority owners
-40.33%-19.07M
-49.11%-13.33M
-62.06%-7.42M
-94.19%-18.28M
-128.51%-13.59M
-309.92%-8.94M
---4.58M
---9.42M
---5.95M
---2.18M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 1.28%1.07B2.43%738.59M4.38%372.9M10.84%1.43B13.89%1.06B21.74%721.05M22.36%357.27M12.74%1.29B14.97%926.99M14.02%592.31M
Operating revenue 1.28%1.07B2.43%738.59M4.38%372.9M10.84%1.43B13.89%1.06B21.74%721.05M22.36%357.27M12.74%1.29B14.97%926.99M14.02%592.31M
Total operating cost 4.19%924.38M4.94%634.77M4.65%321.93M8.88%1.21B10.52%887.21M18.93%604.89M20.34%307.62M13.08%1.11B15.15%802.78M13.26%508.6M
Operating cost 7.89%402.68M4.41%274.93M-2.96%133.12M20.89%504.55M27.13%373.25M43.13%263.33M40.16%137.19M31.82%417.38M36.33%293.6M27.22%183.98M
Operating tax surcharges 52.33%18.09M74.71%11.75M10.34%3.33M14.09%19.28M18.36%11.88M6.52%6.72M23.62%3.01M20.22%16.9M6.87%10.03M-4.14%6.31M
Operating expense -3.53%369.27M-0.62%250.92M12.04%138.26M-3.51%528.1M-7.13%382.78M-4.79%252.48M-4.80%123.4M2.50%547.31M5.84%412.16M8.88%265.17M
Administration expense 0.39%47.08M10.02%32.81M22.44%16.97M38.22%67.25M41.73%46.9M36.63%29.82M32.92%13.86M-6.43%48.65M-15.34%33.09M0.48%21.83M
Financial expense -312.57%-13.3M1.57%-2.12M-335.72%-1.17M-62.07%-12.32M32.79%-3.22M21.69%-2.15M78.21%-269.42K-92.05%-7.6M-92.33%-4.8M-1,074.75%-2.74M
-Interest Income (Financial expense) -358.41%-13.68M-11.46%-1.99M-151.04%-1.15M-71.79%-12.44M28.19%-2.98M34.33%-1.78M-343.44%-456.44K-74.00%-7.24M-60.60%-4.16M-498.15%-2.71M
Research and development 32.94%100.56M21.54%66.47M3.29%31.43M16.37%103.18M28.86%75.64M60.63%54.69M84.33%30.43M26.57%88.67M26.49%58.7M3.82%34.05M
Credit Impairment Loss 104.39%337.55K-630.78%-2.32M-680.79%-1.1M31.34%-1.58M107.79%165.15K21.46%-316.81K131.36%188.57K-39.74%-2.3M-123.38%-2.12M0.79%-403.39K
Asset Impairment Loss 53.32%-2.41M14.38%-2.58M-24.40%-1.16M-67.55%-7.59M-198.80%-5.17M-3,732.55%-3.01M-2,489.52%-932.1K-67.76%-4.53M-1,246.94%-1.73M-117.79%-78.59K
Other net revenue
Invest income -818.25%-11.4M-246.72%-4.14M-266.89%-2.85M-55.06%3.58M-82.41%1.59M-59.73%2.82M-42.02%1.71M367.29%7.98M956.45%9.02M648.54%7.01M
-Including: Investment income associates -189.28%-11.39M-151.58%-4.2M-136.21%-2.9M-5.91%-5.04M-135.96%-3.94M-105.96%-1.67M-2.88%-1.23M-86.18%-4.76M10.00%-1.67M56.83%-810.58K
Asset deal income ----------0--200.27100.03%200.27100.16%200.27100.91%200.27-----395.76%-673.9K-83.33%-121.45K
Other revenue 197.81%32.09M167.97%26.5M639.58%21.55M47.68%19.95M18.27%10.78M76.71%9.89M133.23%2.91M-35.24%13.51M-44.48%9.11M-59.78%5.6M
Operating profit -7.02%163.53M-3.39%121.29M25.96%67.42M20.97%237.11M27.62%175.88M31.17%125.55M34.00%53.52M7.76%196M11.79%137.81M15.26%95.71M
Add:Non operating Income -47.16%19.54K-92.22%1.91K-86.40%1.71K-39.81%58.41K-49.90%36.99K-65.34%24.59K580.70%12.59K-72.20%97.05K-76.83%73.83K2,187.97%70.93K
Less:Non operating expense -98.00%111.51K-98.32%91.46K-58.67%7.33K540.46%7.29M1,718.65%5.58M2,578.06%5.46M-82.30%17.74K-48.46%1.14M-90.45%306.77K-93.65%203.86K
Total profit -4.05%163.44M0.91%121.2M25.96%67.41M17.91%229.88M23.81%170.34M25.67%120.11M34.31%53.52M8.29%194.96M14.29%137.58M19.72%95.58M
Less:Income tax cost -6.05%24.11M29.10%21.74M67.31%14.78M70.78%36.84M32.35%25.66M20.81%16.84M53.52%8.83M11.95%21.57M13.22%19.39M30.68%13.94M
Net profit -3.69%139.34M-3.69%99.46M17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M14.46%118.19M18.03%81.64M
Net profit from continuing operation -3.69%139.34M-3.69%99.46M17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M--118.19M18.03%81.64M
Less:Minority Profit -40.33%-19.07M-49.11%-13.33M-62.06%-7.42M-94.19%-18.28M-128.51%-13.59M-309.92%-8.94M---4.58M---9.42M---5.95M---2.18M
Net profit of parent company owners 0.09%158.41M0.52%112.79M21.90%60.05M15.60%211.32M27.49%158.27M33.87%112.21M44.50%49.26M13.71%182.8M20.22%124.14M21.19%83.82M
Earning per share
Basic earning per share 0.00%1.690.00%1.220.75%0.6415.38%2.2528.03%1.6934.83%1.247.22%0.53-2.99%1.9520.00%1.32-9.18%0.89
Diluted earning per share 0.00%1.690.00%1.220.75%0.6415.38%2.2528.03%1.6934.83%1.247.22%0.53-2.99%1.9520.00%1.32-9.18%0.89
Other composite income
Total composite income -3.69%139.34M-3.69%99.46M17.79%52.63M11.33%193.04M22.41%144.68M26.50%103.27M31.07%44.68M7.86%173.39M118.19M18.03%81.64M
Total composite income of parent company owners 0.09%158.41M0.52%112.79M21.90%60.05M15.60%211.32M27.49%158.27M33.87%112.21M44.50%49.26M13.71%182.8M--124.14M21.19%83.82M
Total composite income of minority owners -40.33%-19.07M-49.11%-13.33M-62.06%-7.42M-94.19%-18.28M-128.51%-13.59M-309.92%-8.94M---4.58M---9.42M---5.95M---2.18M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Specialized, Special and New
Specialized, Special and New
Intraday+1.58%